1. Characterization of the in vitro and in vivo properties of CFZ533, a blocking and non‐depleting anti‐CD40 monoclonal antibody. Issue 12 (24th May 2018) Authors: Ristov, Jacinda; Espie, Pascal; Ulrich, Peter; Sickert, Denise; Flandre, Thierry; Dimitrova, Mirela; Müller‐Ristig, Dorothee; Weider, Doris; Robert, Gautier; Schmutz, Patrick; Greutmann, Barbara; Cordoba‐Castro, Francisco; Schneider, Martin A.; Warncke, Max; Kolbinger, Frank; Cote, Serge; Heusser... Journal: American journal of transplantation Issue: Volume 18:Issue 12(2018) Page Start: 2895 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ligelizumab treatment for severe asthma: learnings from the clinical development programme. Issue 3 (15th March 2021) Authors: Trischler, Jordis; Bottoli, Ivan; Janocha, Reinhold; Heusser, Christoph; Jaumont, Xavier; Lowe, Phil; Gautier, Aurelie; Pethe, Abhijit; Woessner, Ralph; Zerwes, Hans‐Günter; Zielen, Stefan Journal: Clinical & translational immunology Issue: Volume 10:Issue 3(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗